EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early neutrophil responses are potential biomarkers to predict severe COVID-19 in adults

Ananya Singh iD, Nurhidayah Binte Mohamed Yazid, Raika Francesca Morales, Keisuke Ejima iD, Po Ying Chia, Siew Wai Fong, Lisa F P Ng, Laurent Renia, David Chien Lye, Lousia Jin Sun, Seow Yen Tan iD, Louis Yi Ann Chai iD und 4 weitere

Journal of Leukocyte Biology · 2025

DOI: 10.1093/jleuko/qiaf035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2025. Verfasst von Ananya Singh und 15 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore. Hauptthemen laut MEDLINE: COVID-19, Neutrophils, SARS-CoV-2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lee Kong Chian School of Medicine Dean's Postdoctoral Fellowship, Startup University Grant from the Singapore Ministry of Education, US Food and Drug Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the early COVID-19 pandemic, the strain on healthcare facilities highlighted the need for reliable biomarkers to predict progression to severe COVID-19. Neutrophils, the most abundant leukocytes in circulation, are early defenders against pathogens. In a Singaporean adult cohort, early neutrophil mediators were assessed for their suitability as prognostic biomarkers of COVID-19 complications. Plasma levels of myeloperoxidase (MPO), elastase, soluble urokinase plasminogen activator receptor (suPAR), and soluble suppressor of tumorigenicity 2 (sST2) in 35 nonsevere and 14 severe cases were measured twice, 2 to 7 d apart after hospitalization. Nineteen controls were included. The levels of MPO, elastase, suPAR, and sST2 were significantly higher in patients with severe COVID-19 compared with those with mild and healthy controls. At baseline sampling, MPO and suPAR predicted severe COVID-19 and had AUROCs of 0.76 and 0.87, respectively. MPO and suPAR at cut-off values of 26.41 ng/mL and 3.19 ng/mL, respectively showed approximately 71% sensitivity and 81% to 84% specificity to differentiate severe COVID-19. In contrast, elastase and neutrophil counts were less predictive of severe disease. In adult COVID-19, MPO and suPAR may be reliable prognostic biomarkers of severe disease during acute COVID-19. Further validation of these markers in a larger cohort and in other infectious diseases is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19NeutrophilsSARS-CoV-2HumansBiomarkersMaleFemaleMiddle AgedAdultPeroxidaseAgedReceptors, Urokinase Plasminogen ActivatorSeverity of Illness IndexPrognosisPancreatic Elastase

Stichwörter der Autor:innen

infectious diseasesmyeloperoxidaseneutrophilsrespiratory infectionssoluble urokinase plasminogen activator receptor (suPAR)

Substanzen

BiomarkersPeroxidaseReceptors, Urokinase Plasminogen ActivatorPancreatic ElastaseMPO protein, humanPLAUR protein, human

Autor:innen und Institutionen

  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.
  • National Centre for Infectious Diseases, Singapore 308442, Singapore.
  • Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore 308442, Singapore.
  • A*STAR Infectious Diseases Lab, Agency for Science and Technology and Research (A*STAR), Singapore 138648, Singapore.
  • Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L69 7ZX, United Kingdom.
  • National Institute of Health Research, Health Protection Research Unit in Emerging and Zoonotic Infections, University of Liverpool, Liverpool L69 7ZX, United Kingdom.

ORCID-Profile: Ananya Singh, Keisuke Ejima, Seow Yen Tan, Louis Yi Ann Chai, Shirin Kalimuddin, Andrew Teo

Förderung

  • Lee Kong Chian School of Medicine Dean's Postdoctoral Fellowship
  • Startup University Grant from the Singapore Ministry of Education
  • US Food and Drug Administration
  • Agency for Science, Technology and Research (A*STAR) and A*STAR COVID-19 Research funding
  • A*STAR Infectious diseases Lab
  • NMRC

Zitieren

APA

Singh, A., Yazid, N. B. M., Morales, R. F., Ejima, K., Chia, P. Y., Fong, S. W., Ng, L. F. P., Renia, L., Lye, D. C., Sun, L. J., Tan, S. Y., Chai, L. Y. A., Kalimuddin, S., Young, B. E., Yeo, T. W., & Teo, A. (2025). Early neutrophil responses are potential biomarkers to predict severe COVID-19 in adults. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiaf035

Vancouver

Singh A, Yazid NBM, Morales RF, Ejima K, Chia PY, Fong SW, et al. Early neutrophil responses are potential biomarkers to predict severe COVID-19 in adults. Journal of Leukocyte Biology. 2025. doi:10.1093/jleuko/qiaf035

BibTeX
@article{Singh2025,
  author = {Singh, Ananya and Yazid, Nurhidayah Binte Mohamed and Morales, Raika Francesca and Ejima, Keisuke and Chia, Po Ying and Fong, Siew Wai and Ng, Lisa F P and Renia, Laurent and Lye, David Chien and Sun, Lousia Jin and Tan, Seow Yen and Chai, Louis Yi Ann and Kalimuddin, Shirin and Young, Barnaby Edward and Yeo, Tsin Wen and Teo, Andrew},
  title = {Early neutrophil responses are potential biomarkers to predict severe COVID-19 in adults},
  journal = {Journal of Leukocyte Biology},
  year = {2025},
  doi = {10.1093/jleuko/qiaf035}
}
Kostenlos starten →